ARMY HEALTH SERVICES COMMAND FORMING PHARMACOECONOMIC CENTER
ARMY HEALTH SERVICES COMMAND FORMING PHARMACOECONOMIC CENTER in an effort to bring soaring drug expenditures at Army medical facilities in the U.S. under better control. HSC pharmaceutical expenditures have increased from 46% to 51% of "expendable supply dollars" in the past five years. Expendable supplies include medical and surgical supplies that are used up, but not major medical equipment or payroll. HSC pharmaceutical expenditures totaled $230 mil. in FY 1992 (ended Oct. 1), a 24% increase over the $185 mil. spent in FY 1991. The pharmacoeconomic center will be located at the Brooke Army Medical Center in San Antonio and consist of 11 personnel. The center, which the Army expects will begin operating in January, will create educational programs and target specific drugs in an effort to promote cost-effective drug use in U.S. Army medical centers. HSC also is assembling 25 pharmacists who will be assigned to the Army's 25 largest U.S. hospitals to implement the pharmacoeconomic center's policies, ideas and education programs. The U.S. Health Services Command has allotted $2.3 mil. to its pharmaco-economic education push in 1993, and hopes the effort will save the Army $6.1 mil. over the same time period. The program may not lead to a decrease in the Command's pharmaceutical budget. It may even increase, provided that overall expenditures are decreased, Col. James Wilson, pharmacy consultant to the Army Surgeon General, explained. He noted that one challenge the program faces, specifically in the ambulatory care area, is finding a method to assess whether the program is saving money indirectly. The pharmacoeconomic center employees will consist of pharmacists, clerical staff and at least one full-time physician, with additional physicians acting in an advisory capacity. HSC is also considering contracting some pharmacoeconomic work from pharmacy schools, including cost effectiveness assessments of new drugs entering the market. The 25 clinical pharmacists will focus primarily on prescriber education and secondarily on pharmaceutical use in the ambulatory care setting. Most of these pharmacists will be civilians hired specifically for the job, and some will be reassigned from other Army posts.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth